Labs in Court Weekly Roundup
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
False and fraudulent claims, particularly those relating to COVID-19 and telemedicine, made up most of the key enforcement actions announced by the DOJ this past week
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
A recent AMP report offers recommendations to policymakers to prevent problems in future public health emergencies.
Company involved in recent Class 1 recalls of COVID-19 rapid tests now faces further fallout by not refunding customers for faulty tests.
Starting April 4, Medicare beneficiaries can get eight free tests per month for each month the public health emergency remains in effect.